{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:02Z","timestamp":1786123202526,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The prevalence of opioid misuse and opioid-related mortality has increased dramatically over the past decade. There is limited evidence on factors associated with mortality from opioid overdose in the inpatient setting. The primary objective was to report national trends in opioid overdose and mortality. The secondary objectives were to explore factors associated with inpatient mortality and report differences in prescription opioid overdose (POD) versus illicit opioid overdose (IOD) cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Using the 2010\u20132014 Nationwide Inpatient Sample, we performed a cross-sectional analysis and identified a weighted estimate of 570,987 adult patients with an International Classification of Disease, Ninth Revision, or External Cause of Injury code of POD or IOD. We performed multivariable logistic regression to identify predictors of inpatient mortality. The odds ratio (OR) and their associated 95% confidence interval (CI) are reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of the 570,987 patients with opioid overdose, 13.8% had an admissions diagnosis of IOD, and the remaining had POD. Among all opioid overdose admissions, the adjusted odds of IOD admissions increased by 31% per year (OR, 1.31; 95% CI, 1.29\u20131.31;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001); however, the adjusted odds POD admissions decreased by 24% per year (OR, 0.76; 95% CI, 0.75\u20130.77;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). The mortality was 4.7% and 2.3% among IOD and POD admissions, respectively. The odds of inpatient mortality increased by 8% per year among IOD admissions (OR, 1.08; 95% CI, 1.02\u20131.14;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .007). The odds of inpatient mortality increased by 6% per year among all POD admissions (OR, 1.06; 95% CI, 1.03\u20131.09;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Those with IOD compared to POD had higher odds of mortality (OR, 2.03; 95% CI, 1.79\u20132.29;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Patients with age \u226580 years of age and those with a diagnosis of a solid tumor malignancy had higher odds of mortality. Odds of inpatient mortality were decreased in African American versus Caucasian patients and in patients undergoing alcohol rehabilitation therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The increase in mortality provides a strong basis for further risk reduction strategies and intervention program implementation. Medical management of not only the opioid overdose but also the comorbidities calls for a multidisciplinary approach that involves policy makers and health care teams.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003755","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T08:51:26Z","timestamp":1536310286000},"page":"152-160","source":"Crossref","is-referenced-by-count":14,"title":["National Trends and Factors Associated With Inpatient Mortality in Adult Patients With Opioid Overdose"],"prefix":"10.1213","volume":"128","author":[{"given":"Brittany N.","family":"Burton","sequence":"first","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy T.","family":"Said","sequence":"additional","affiliation":[{"name":"Division of Regional Anesthesia and Acute Pain, Department of Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney A.","family":"Gabriel","sequence":"additional","affiliation":[{"name":"Division of Regional Anesthesia and Acute Pain, Department of Anesthesiology"},{"name":"Division of Biomedical Informatics, Department of Medicine, University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths: United States, 2010-2015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/add.14144","article-title":"Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999\u20132015.","volume":"113","author":"Ruhm","year":"2018","journal-title":"Addiction"},{"key":"R3-20230721","first-page":"1","article-title":"Prescription opioid analgesic use among adults: United States, 1999\u20132012.","author":"Frenk","year":"2015","journal-title":"CDC NCHS Data Brief"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.ajp.0000210915.80417.cf","article-title":"Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.","volume":"22","author":"Birnbaum","year":"2006","journal-title":"Clin J Pain"},{"key":"R5-20230721","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users: United States, 2002-2013.","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","article-title":"US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.","volume":"46","author":"Unick","year":"2017","journal-title":"Int J Drug Policy"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/add.13795","article-title":"Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001-12.","volume":"112","author":"Hsu","year":"2017","journal-title":"Addiction"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/003335491412900507","article-title":"Drug overdose surveillance using hospital discharge data.","volume":"129","author":"Slavova","year":"2014","journal-title":"Public Health Rep"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis.","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S108302","article-title":"Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system.","volume":"7","author":"Boscarino","year":"2016","journal-title":"Subst Abuse Rehabil"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12913-016-1692-z","article-title":"Medical encounters for opioid-related intoxications in Southern Nevada: sociodemographic and clinical correlates.","volume":"16","author":"Feng","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2016.04.022","article-title":"Opioid overdose leading to intensive care unit admission: epidemiology and outcomes.","volume":"35","author":"Pfister","year":"2016","journal-title":"J Crit Care"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11524-015-9967-y","article-title":"Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities.","volume":"92","author":"Visconti","year":"2015","journal-title":"J Urban Health"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","article-title":"Trends in opioid analgesic-prescribing rates by specialty, US, 2007-2012.","volume":"49","author":"Levy","year":"2015","journal-title":"Am J Prev Med"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/JPR.S129553","article-title":"Secular trends in opioid prescribing in the USA.","volume":"10","author":"Pezalla","year":"2017","journal-title":"J Pain Res"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006-2015.","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addbeh.2018.03.014","article-title":"Opioid-overdose laws association with opioid use and overdose mortality.","volume":"86","author":"McClellan","year":"2018","journal-title":"Addict Behav"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pds.4404","article-title":"Impact of Florida\u2019s prescription drug monitoring program and pill mill law on high-risk patients: a comparative interrupted time series analysis.","volume":"27","author":"Chang","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0885-3924(92)90047-L","article-title":"The history and development of the fentanyl series.","volume":"7","author":"Stanley","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region: United States, 2006-2015.","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.drugalcdep.2017.05.047","article-title":"Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances.","volume":"178","author":"Kandel","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.","volume":"103","author":"Schwartz","year":"2013","journal-title":"Am J Public Health"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity.","volume":"32","author":"Wakeman","year":"2017","journal-title":"J Gen Intern Med"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08897077.2015.1019662","article-title":"The impact of social support and attachment style on quality of life and readiness to change in a sample of individuals receiving medication-assisted treatment for opioid dependence.","volume":"36","author":"Cavaiola","year":"2015","journal-title":"Subst Abus"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addbeh.2017.05.010","article-title":"Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs.","volume":"73","author":"Damian","year":"2017","journal-title":"Addict Behav"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1086\/593303","article-title":"Stepwise model fitting and statistical inference: turning noise into signal pollution.","volume":"173","author":"Mundry","year":"2009","journal-title":"Am Nat"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/sim.4780080702","article-title":"Bootstrap investigation of the stability of a Cox regression model.","volume":"8","author":"Altman","year":"1989","journal-title":"Stat Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201901000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:19Z","timestamp":1786112539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201901000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003755","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}